129 related articles for article (PubMed ID: 12167390)
1. The incomplete bucindolol evaluation in acute myocardial infarction Trial (BEAT).
Torp-Pedersen C; Køber L; Ball S; Hall A; Brendorp B; Ottesen M; Berning J; Jensen G; Hampton J; Zilles P; Eberle S; Carlsen J
Eur J Heart Fail; 2002 Aug; 4(4):495-9. PubMed ID: 12167390
[TBL] [Abstract][Full Text] [Related]
2. The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials?
Otterstad JE; Ford I
Eur J Heart Fail; 2002 Aug; 4(4):501-6. PubMed ID: 12167391
[TBL] [Abstract][Full Text] [Related]
3. Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol.
Eichhorn EJ; Bedotto JB; Malloy CR; Hatfield BA; Deitchman D; Brown M; Willard JE; Grayburn PA
Circulation; 1990 Aug; 82(2):473-83. PubMed ID: 1973638
[TBL] [Abstract][Full Text] [Related]
4. Myocardial contractile reserve by dobutamine stress echocardiography predicts improvement in ejection fraction with beta-blockade in patients with heart failure: the Beta-Blocker Evaluation of Survival Trial (BEST).
Eichhorn EJ; Grayburn PA; Mayer SA; St John Sutton M; Appleton C; Plehn J; Oh J; Greenberg B; DeMaria A; Frantz R; Krause-Steinrauf H
Circulation; 2003 Nov; 108(19):2336-41. PubMed ID: 14597587
[TBL] [Abstract][Full Text] [Related]
5. Impact of nonfatal myocardial infarction on outcomes in patients with advanced heart failure and the effect of bucindolol therapy.
O'Connor CM; Gottlieb S; Bourque JM; Krause-Steinrauf H; Anand I; Anderson JL; Plehn JF; Silver MA; White M; Carson P;
Am J Cardiol; 2005 Mar; 95(5):558-64. PubMed ID: 15721091
[TBL] [Abstract][Full Text] [Related]
6. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure.
; Eichhorn EJ; Domanski MJ; Krause-Steinrauf H; Bristow MR; Lavori PW
N Engl J Med; 2001 May; 344(22):1659-67. PubMed ID: 11386264
[TBL] [Abstract][Full Text] [Related]
7. Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators.
Bristow MR; O'Connell JB; Gilbert EM; French WJ; Leatherman G; Kantrowitz NE; Orie J; Smucker ML; Marshall G; Kelly P
Circulation; 1994 Apr; 89(4):1632-42. PubMed ID: 7908610
[TBL] [Abstract][Full Text] [Related]
8. Failure of benefit and early hazard of bucindolol for Class IV heart failure.
Anderson JL; Krause-Steinrauf H; Goldman S; Clemson BS; Domanski MJ; Hager WD; Murray DR; Mann DL; Massie BM; McNamara DM; Oren R; Rogers WJ;
J Card Fail; 2003 Aug; 9(4):266-77. PubMed ID: 13680547
[TBL] [Abstract][Full Text] [Related]
9. Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure.
Aleong RG; Sauer WH; Robertson AD; Liggett SB; Bristow MR
Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):137-43. PubMed ID: 23275278
[TBL] [Abstract][Full Text] [Related]
10. [Beta blockers in post-infarction state].
Schultheiss HP; Tschöpe C
Herz; 2002 Aug; 27 Suppl 1():26-9. PubMed ID: 12229255
[TBL] [Abstract][Full Text] [Related]
11. Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation.
Kao DP; Davis G; Aleong R; O'Connor CM; Fiuzat M; Carson PE; Anand IS; Plehn JF; Gottlieb SS; Silver MA; Lindenfeld J; Miller AB; White M; Murphy GA; Sauer W; Bristow MR
Eur J Heart Fail; 2013 Mar; 15(3):324-33. PubMed ID: 23223178
[TBL] [Abstract][Full Text] [Related]
12. Carvedilol saves lives--new data from landmark trials prove survival benefits in heart failure and post myocardial infarction.
Cardiovasc J S Afr; 2001; 12(2):122-3. PubMed ID: 11474697
[No Abstract] [Full Text] [Related]
13. Hemodynamic and energetic comparison of bucindolol and metoprolol for the treatment of congestive heart failure.
Heesch CM; Marcoux L; Hatfield B; Eichhorn EJ
Am J Cardiol; 1995 Feb; 75(5):360-4. PubMed ID: 7856528
[TBL] [Abstract][Full Text] [Related]
14. New evidence from the CAPRICORN Trial: the role of carvedilol in high-risk, post-myocardial infarction patients.
Sackner-Bernstein JD
Rev Cardiovasc Med; 2003; 4 Suppl 3():S25-9. PubMed ID: 14564231
[TBL] [Abstract][Full Text] [Related]
15. Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population: The GENETIC-AF Trial.
Piccini JP; Abraham WT; Dufton C; Carroll IA; Healey JS; van Veldhuisen DJ; Sauer WH; Anand IS; White M; Wilton SB; Aleong R; Rienstra M; Krueger SK; Ayala-Paredes F; Khaykin Y; Merkely B; Miloradović V; Wranicz JK; Ilkhanoff L; Ziegler PD; Davis G; Emery LL; Marshall D; Kao DP; Bristow MR; Connolly SJ;
JACC Heart Fail; 2019 Jul; 7(7):586-598. PubMed ID: 31042551
[TBL] [Abstract][Full Text] [Related]
16. Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
Frantz RP; Lowes BD; Grayburn PA; White M; Krause-Steinrauf H; Krishnan V; Uyeda L; Burnett JC;
J Card Fail; 2007 Aug; 13(6):437-44. PubMed ID: 17675057
[TBL] [Abstract][Full Text] [Related]
17. Congestive heart failure with preserved left ventricular systolic function after acute myocardial infarction: clinical and prognostic implications.
Møller JE; Brendorp B; Ottesen M; Køber L; Egstrup K; Poulsen SH; Torp-Pedersen C;
Eur J Heart Fail; 2003 Dec; 5(6):811-9. PubMed ID: 14675860
[TBL] [Abstract][Full Text] [Related]
18. [The use of esmolol in patients with myocardial infarction complicated with acute left ventricular failure].
Tereshchenko SN; Kositsyna IV; Dzhaiani NA; Golubev AV; Kochetov AG
Kardiologiia; 2005; 45(6):19-22. PubMed ID: 16007029
[TBL] [Abstract][Full Text] [Related]
19. Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy.
Woodley SL; Gilbert EM; Anderson JL; O'Connell JB; Deitchman D; Yanowitz FG; Mealey PC; Volkman K; Renlund DG; Menlove R
Circulation; 1991 Dec; 84(6):2426-41. PubMed ID: 1683602
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic drug evaluation of bucindolol for the treatment of atrial fibrillation in heart failure patients.
Rosa GM; Meliota G; Brunelli C; Ferrero S
Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):473-481. PubMed ID: 28162002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
